A2Z Cust2Mate Strengthens Retail Media Position as Advertisers Tap Smart Carts for In-Store Reach

The Dyrt Creates Comprehensive Pacific Coast Highway Road Trip and Camping Guide Presented by T-Mobile

Victoria’s Secret & Co. Board Comments on BBRC’s Distracting Proxy Contest; Underscores Significant Outperformance and Board’s Commitment to Acting in the Best Interest of Shareholders

Ocugen Provides Business Update with First Quarter 2026 Financial Results

Kopin Awarded $21.5 Million Follow‑On Production Contract to Deliver U.S.‑Made Thermal Imaging Assemblies for a Major Defense Prime

Chanson International Holding Announces 100 for 1 Share Consolidation

Foremost Clean Energy Advances CLK Uranium Property With Results of MobileMT and Ambient Noise Tomography Surveys Following up Historic High-Grade Showing

Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026

Eagle Nuclear Energy Announces Commencement of Environmental Baseline Studies in Advance of PFS-Related Drill Program at Aurora

Extreme Solidifies Networking Leadership with Major Enhancements to Extreme Platform ONE

Expeditors Reports First Quarter 2026 EPS of $1.71

PTC Codebeamer Replaces Legacy System at Hamilton Medical

Lightwave Logic, Inc. Announces Timing of First Quarter 2026 Financial Results and Business Update Call

MicroAlgo Inc.'s Quantum Blockchain Architecture Using Cyclic QSC and QKD to Enhance Transaction Security and Transparency

SAB BIO to Host First Quarter 2026 Financial Results Conference Call and Webcast on May 12, 2026, 08:30 AM ET

MFA Financial, Inc. Announces First Quarter 2026 Financial Results

Microbot Medical®’s LIBERTY® Endovascular Robotic System is Now Adopted by Multiple Accounts Across Key Territories Including Two ACCESS-PVI Pivotal Clinical Trial Sites

Pioneering AI Inference Acceleration Provider Selects Silicom's Inference-Specific Solution

Perma-Fix Schedules First Quarter 2026 Business Update Conference Call

Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis